Seelos Therapeutics Inc logo

Seelos Therapeutics Inc Share Price (NASDAQ: SEEL)

▲

-1.17

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 16 Oct 2024

Check the interactive Seelos Therapeutics Inc Stock chart to analyse performance

Seelos Therapeutics Inc Key Stats

Check Seelos Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.17
Open
$1.0
Market Capitalization
$743.7K
Today's Volume
$128.1K
Revenue TTM
$2.0M
EBITDA
$-27.7M
Earnings Per Share (EPS)
$351.04
PE Ratio
0.0
Profit Margin
203.13%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-584.2%

Global Institutional Holdings in Seelos Therapeutics Inc

  • Name

    Holdings %

  • AdvisorShares Investments, LLC

    1.29%

  • WEALTH EFFECTS LLC

    0.77%

  • Morgan Stanley - Brokerage Accounts

    0.32%

  • Modera Wealth Management, LLC

    0.31%

  • Geode Capital Management, LLC

    0.18%

  • BlackRock Inc

    0.10%

Analyst Recommendation on Seelos Therapeutics Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Seelos Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Seelos Therapeutics Inc

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene and alpha synuclein; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; SLS-007, a peptidic inhibitor for NACore Parkinson disease; and SLS-009, a protein targeted autophagy for Alzheimer disease. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Organization
Seelos Therapeutics Inc
Employees
8
CEO
Dr. Raj Mehra J.D., Ph.D.
Industry
Pharmaceuticals: Other

Important FAQs about investing in SEEL Stock from India :

What is Seelos Therapeutics Inc share price today?

Seelos Therapeutics Inc share price today is as on at the close of the market. Seelos Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Seelos Therapeutics Inc share?

Seelos Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Seelos Therapeutics Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Seelos Therapeutics Inc Stock (SEEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Seelos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seelos Therapeutics Inc Shares .

What is the minimum amount required to buy Seelos Therapeutics Inc Stock (SEEL) from India?

Indian investors can start investing in Seelos Therapeutics Inc (SEEL) shares with as little as ₹88.3 or $1 (as of September 14, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹883.00 in Seelos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025). Learn more about fractional shares .

What are the returns that Seelos Therapeutics Inc has given to Indian investors in the last 5 years?

Seelos Therapeutics Inc stock has given 0.0% share price returns and 20.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?